People in the News
Peter Buckel has stepped down as CEO of Atugen following the company's recent acquisition by UK-based SR Pharma.
Buckel joined Atugen early last year (see RNAi News, 4/23/2004) after serving as CEO of Xantos Biomedicine, a company he co-founded. Prior to this, he was senior vice president of molecular medicine for Roche Diagnostics.
Products & Services